HemoCue Hemoglobin Testing Webinar

Event Details

Originally Aired: Monday, August 22

Time: 2:00 PM EDT

Presenter: Joseph Thomas, BSN, RN

Unless otherwise noted, P.A.C.E.™ accreditation will expire six months after the live webinar.

Impact of Point of Care Hemoglobin Testing on Patient Blood Management.

Published studies show that between 40% to 60% of transfusions are inappropriate, suggesting no benefit or worse – harm to patients.¹ Additionally, one-third of transfusions in the operating room are given without a lab hemoglobin measurement.²

Fisher HealthCare presents a complimentary, PACE-accredited webinar that will focus on Patient Blood Management (PBM) and Point-of-care Hemoglobin testing.

PBM is an emerging clinical concept designed to reduce unnecessary, excessive and avoidable blood transfusions. Interest in PBM has grown rapidly throughout the world as new evidence demonstrates a strong association between transfusion and a variety of healthcare complications (infections, pulmonary injury, and mortality). Reducing transfusion exposure in hospitals has the dual benefit of significantly reducing costs while improving safety and outcomes. 

PBM programs often utilize a variety of resources and technologies to optimize blood management, including point-of-care testing. Point-of-care Hemoglobin testing has been widely used in hospitals and published in the literature as an evidence-based strategy to support transfusion management. This presentation will focus on practical applications of POCT Hgb to improve the recognition and management of anemia, support the paradigm shift of RBC transfusion as single units with reassessment, and optimize transfusion decision making in the anemic or bleeding patient.

Watch On Demand      View Slides

Learning Objectives

1. Describe how optimal transfusion practice and patient blood management can result in reduced health care costs and improved patient outcomes
2. Define how point-of-care Hemoglobin testing can improve recognition/management of anemia and transfusion decision making in the bleeding patient

1 Koch CG, Li L, Duncan Al, et al. Morbidity and mortality risk associated with red blood cells and blood- component transfusion in isolated coronary artery bypass grafting. Crit Care Med. 2006 Jun;34(6):1608-16.

2 Shander A, Fink A, Javidroozi et al International Consensus Conference on Transfusion Outcomes Group. Appropriateness of allogeneic red blood cell transfusion: the international consensus conference on transfusion outcomes. Transfus Med Rev. 2011; 25(3):232-246.e53